Cambier, M., Muller, F., Vanderstichelen, G., Remacle, C., Henket, M., Guiot, J., & Struman, I. (17 May 2023). Extracellular vesicles in circulation in the identification of immune checkpoint associated with lung cancer [Poster presentation]. ISEV Annual Meeting, Seattle, United States. |
  | Zamberlan, M.* , Boeckx, A.* , Muller, F., Vinelli, F., Ek, O., Vianello, C., Coart, E., Shibata, K., Christian, A., Grespi, F., Giacomello, M., Struman, I., Scorrano, L.* , & Herkenne, S.*. (12 March 2022). Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. Journal of Experimental and Clinical Cancer Research, 41 (1), 95. doi:10.1186/s13046-022-02304-6  Peer reviewed* These authors have contributed equally to this work. |
Cambier, M., Muller, F., Remacle, C., Guiot, J., & Struman, I. (2022). EVs as diagnostic tool in the phenotypic determination of lung tumors [Poster presentation]. BESEV annual meeting, Anvers, Belgium. |
Cambier, M., Muller, F., Henket, M., Guiot, J., & Struman, I. (2021). Exosomes as diagnostic tools in the phenotypic determination of lung tumors [Poster presentation]. GIGA-CANCER DAY 2021. |
  | Mhaidly, R., Mondragon, L., De Donatis, G. M. (Other coll.), Tosselini, M. (Other coll.), Dao, P. (Other coll.), Martin, A. (Other coll.), Pons, C. (Other coll.), Chiche, J. (Other coll.), Jacquin, M. (Other coll.), Imbert, V. (Other coll.), Proïcs, E. (Other coll.), Rubio-Patino, C. (Other coll.), Bossowski, J. P. (Other coll.), Marchetti, S. (Other coll.), Villa, E. (Other coll.), Peyron, J.-F. (Other coll.), Genestier, L. (Other coll.), Benhida, R. (Other coll.), Fournié, J.-J. (Other coll.), ... Verhoeyen, E. (Other coll.). (2019). GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-kB dependent mechanism (Muller, F., Trans.). Cancer Cell. doi:10.1016/j.ccell.2019.07.008 Peer Reviewed verified by ORBi |
 | Diederich, M., Muller, F., & Cerella, C. (2017). Cardiac glycosides: From molecular targets to immunogenic cell death. Biochemical Pharmacology, 125, 1-11. doi:10.1016/j.bcp.2016.08.017 Peer Reviewed verified by ORBi |
 | Sobolewski, C., Muller, F., Cerella, C., Dicato, M., & Diederich, M. (2015). Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model. Molecular Carcinogenesis, 54 (10), 999-1013. doi:10.1002/mc.22169 Peer Reviewed verified by ORBi |
 | Cerella, C., Muller, F., Gaigneaux, A., Radogna, F., Viry, E., Chateauvieux, S., Dicato, M., & Diederich, M. (2015). Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450. Cell death & disease, 6, 1782. doi:10.1038/cddis.2015.134 Peer reviewed |
 | Sobolewski, C., Rhim, J., Legrand, N., Muller, F., Cerella, C., Mack, F., Chateauvieux, S., Kim, J.-G., Yoon, A.-Y., Kim, K.-W., Dicato, M., & Diederich, M. (2015). 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells. Journal of Pharmacology and Experimental Therapeutics, 355 (2), 308-28. doi:10.1124/jpet.115.225011 Peer Reviewed verified by ORBi |
 | Muller, F., Cerella, C., Radogna, F., Dicato, M., & Diederich, M. (2015). Effects of Natural Products on Mcl-1 Expression and Function. Current Medicinal Chemistry, 22 (30), 3447-61. doi:10.2174/0929867322666150716115435 Peer Reviewed verified by ORBi |
Muller, F. (2014). IDENTIFICATION DES CIBLES MOLECULAIRES DES COMPOSES DE LA FAMILLE DES GLYCOSIDES CARDIAQUES [Doctoral thesis, Université de Lorraine]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/236028 |
 | Sobolewski, C., Viry, E., Legrand, N., Muller, F., Morceau, F., & Diederich, M. (2011). Integrated cellular pathology--systems biology of human diseases. Biochemical Pharmacology, 82 (10), 1253-5. doi:10.1016/j.bcp.2011.05.032 Peer Reviewed verified by ORBi |